Plain-English translation of NCT05928598 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a tablet-based planning tool — called the Epilepsy Visit Planner — helps patients with drug-resistant epilepsy get more out of their clinic visits. The tool is designed to help you communicate better with your epilepsy doctor by planning what you want to discuss before your appointment. Researchers want to see if using this tool improves your quality of life and your conversations with your care team.
Many patients with drug-resistant epilepsy struggle to make the most of their clinic visits and don't always feel heard by their doctors. This trial exists to test whether a simple planning tool can bridge that gap and help patients and doctors work together more effectively.
You likely qualify if…
You likely don't qualify if…
Some participants will receive standard clinic care without the planning tool, while others will use the Epilepsy Visit Planner on a tablet in the waiting room before their appointment. Both groups will complete questionnaires about their communication with their doctor and their quality of life. The trial is being conducted at the University of Michigan, so participants should be prepared to attend their regular epilepsy clinic appointments and spend a little extra time completing surveys.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
University of Michigan
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment target
~152 participants
Started
September 2023
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Queen Bolden
University of Michigan
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.